Background: This study aimed to identify risk factors affecting cancer-specific survival (CSS) and overall survival (OS) in patients with lung squamous cell carcinoma (LSCC) and to develop nomograms for prognostic prediction in these patients.
Introduction
In recent decades, lung cancer, including squamous cell carcinoma, adenocarcinoma, undifferentiated/large cell carcinoma, and small cell lung cancer 1 3 , has received close attention and become an important public health issue worldwide 4, 5 . Lung cancer, the most common cancer in the world, affected 1.8 million patients and caused 1.6 million deaths in 2012 6 . Lung squamous cell carcinoma (LSCC) represents 30% to 50% of all lung cancers. It is one of the most frequent histological subtypes and is closely related to tumor mortality 7 . Accumulating evidence indicates that LSCC is associated with many chronic diseases and disorders, including diabetes, hypertension, obesity, and metabolic syndrome 8 10 , thus dramatically increasing its clinical and economic burden 11 .
Because of the seriousness of LSCC, a technically feasible, readily available grading system is needed in order to stratify prognosis.
Nomograms have been used extensively to predict prognoses 12, 13 . By integrating important prognostic variables, a nomogram can accurately estimate survival of individual patients. However, few researchers have used crowd data to develop a visual tool for LSCC prognostication. Therefore, we used data from the Surveillance, Epidemiology, and End Results (SEER) database to identify risk factors for cancer-specific survival (CSS) and overall survival (OS) and develop a nomogram to evaluate LSCC prognosis.
Materials and Methods
Data for the present patients with LSCC were retrieved from the SEER database registry of the National Cancer Institute by using SEER*Stat software Version 8.3.5 14 . The SEER database is an aggregation of population-based variables and information on primary tumor characteristics, cancer prevalence, incidence, mortality, and treat- 
Results

Patient Demographic and Pathological Characteristics
Survival Analysis
To identify predictors of survival, data from all 23,004 patients were included in univariate and multivariate 
Discussion
In this study, we analyzed data from 23,004 cases in the SEER database to establish and validate a prognostic nomograms for predicting CSS and OS incidence at 3, 5, and 7 years for LSCC. The results of internal bootstrap resampling to evaluate discriminant performance of the nomograms showed that they fit well with actual obser-vations in predicting 3-, 5-, and 7-year CSS and OS rates, according to the C-index.
Because of the high incidence, poor prognosis, recurrence, and metastasis of LSCC, it remains a substantial public health burden worldwide; however, no unified, efficient model to predict survival has been developed for international use. There is thus an urgent need for better strategies to identify patients at high risk for poor survival. Here, we developed two nomograms that utilize 
Conclusions
In summary, using data from an enormous population, we developed and evaluated nomograms for forecasting 3-, 5-, and 7-year CSS and OS that exhibited good prognostic performance in a cohort of patients with LSCC.
